What is Phenotype Screening?
Established in 2004, Phenotype Screening Corporation operates at the intersection of advanced biological science and agricultural productivity. The company specializes in induced expression phenotyping, a sophisticated methodology that allows for the precise assessment of how various treatments influence plant health, gene expression, and structural development. By providing actionable insights into complex biological challenges—such as abiotic stress tolerance, pathogen control, and nutrient utilization—the firm serves as a critical partner for innovative agricultural enterprises seeking to optimize crop performance. Their long-standing expertise in the field enables clients to navigate the complexities of modern farming with data-driven precision, effectively bridging the gap between laboratory research and field-level application.
How much funding has Phenotype Screening raised?
Phenotype Screening has raised a total of $21K across 1 funding round:
Debt
$21K
Debt (2021): $21K with participation from PPP
Key Investors in Phenotype Screening
PPP
Public-Private Partnership
What's next for Phenotype Screening?
With the successful acquisition of this latest financing, Phenotype Screening is poised to transition into a more aggressive growth phase. The strategic deployment of these funds will likely focus on expanding their technological infrastructure and broadening their service offerings to address emerging global food security challenges. As the company scales, it is expected to deepen its integration within the AgTech ecosystem, potentially exploring new partnerships that leverage its unique data sets to drive sustainable agricultural outcomes. The focus remains on maintaining its pioneer status while scaling operations to meet the increasing demand for high-fidelity plant health analytics in a rapidly evolving climate landscape.
See full Phenotype Screening company page
